Skip to main content
. 2020 Sep 4;20:850. doi: 10.1186/s12885-020-07316-z

Fig. 1.

Fig. 1

Distribution of the molecular subtypes for each tumor stage. Distribution in percentages (y-axis) of the CMS groups in the cohort